Arrowstreet Capital’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $118M | Sell |
|
|||||
|
2025
Q2 | $111M | Buy |
|
|||||
|
2025
Q1 | $80.2M | Buy |
|
|||||
|
2024
Q4 | $58.8M | Buy |
|
|||||
|
2024
Q3 | $67.5M | Buy |
|
|||||
|
2024
Q2 | $61.9M | Sell |
|
|||||
|
2024
Q1 | $93.2M | Sell |
|
|||||
|
2023
Q4 | $97.2M | Buy |
|
|||||
|
2023
Q3 | $76.3M | Sell |
|
|||||
|
2023
Q2 | $118M | Sell |
|
|||||
|
2023
Q1 | $126M | Sell |
|
|||||
|
2022
Q4 | $110M | Buy |
|
|||||
|
2022
Q3 | $85.7M | Sell |
|
|||||
|
2022
Q2 | $138M | Sell |
|
|||||
|
2022
Q1 | $229M | Sell |
|
|||||
|
2021
Q4 | $335M | Buy |
|
|||||
|
2021
Q3 | $295M | Buy |
|
|||||
|
2021
Q2 | $175M | Buy |
|
|||||
|
2021
Q1 | $57.1M | Buy |
|
|||||
|
2020
Q4 | $1.9M | Buy |
|
|||||
|
2020
Q3 | $432K | Sell |
|
|||||
|
2020
Q2 | $16.3M | Sell |
|
|||||
|
2020
Q1 | $29.7M | Buy |
|
|||||
|
2019
Q4 | $20M | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $11.6M | Sell |
|
|||||
|
2019
Q1 | $69.9M | Sell |
|
|||||
|
2018
Q4 | $90.7M | Sell |
|
|||||
|
2018
Q3 | $240M | Sell |
|
|||||
|
2018
Q2 | $220M | Sell |
|
|||||
|
2018
Q1 | $206M | Sell |
|
|||||
|
2017
Q4 | $196M | Sell |
|
|||||
|
2017
Q3 | $204M | Buy |
|
|||||
|
2017
Q2 | $212M | Buy |
|
|||||
|
2017
Q1 | $142M | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $63.4M | Buy |
|
|||||
|
2016
Q2 | $26.1M | Buy |
|
|||||
|
2016
Q1 | $3.4M | Buy |
|